Procter & Gamble (NYSE:PG – Get Free Report) had its target price dropped by stock analysts at The Goldman Sachs Group from $159.00 to $155.00 in a report released on Wednesday,MarketScreener reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 5.67% from the stock’s current price.
PG has been the topic of several other reports. Erste Group Bank downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Tuesday, March 24th. Jefferies Financial Group upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price objective for the company from $156.00 to $179.00 in a research report on Tuesday, December 16th. Rothschild & Co Redburn lifted their price objective on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a research report on Friday, January 23rd. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Procter & Gamble from $171.00 to $162.00 and set a “hold” rating on the stock in a research report on Monday, March 30th. Finally, UBS Group cut their price objective on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research report on Tuesday. Twelve investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $164.26.
Read Our Latest Research Report on PG
Procter & Gamble Trading Up 1.2%
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, January 23rd. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.86 by $0.02. The business had revenue of $22.21 billion during the quarter, compared to analyst estimates of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the previous year, the business posted $1.88 EPS. On average, equities analysts forecast that Procter & Gamble will post 6.91 earnings per share for the current year.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 5,549 shares of the business’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $165.29, for a total transaction of $917,194.21. Following the sale, the chief executive officer directly owned 1,029 shares in the company, valued at approximately $170,083.41. The trade was a 84.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary A. Coombe sold 36,093 shares of the business’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the sale, the chief executive officer owned 34,994 shares in the company, valued at $5,680,576.02. This trade represents a 50.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 348,618 shares of company stock worth $55,462,643 in the last three months. Insiders own 0.20% of the company’s stock.
Institutional Trading of Procter & Gamble
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Carson Advisory Inc. raised its position in shares of Procter & Gamble by 0.5% during the 4th quarter. Carson Advisory Inc. now owns 12,124 shares of the company’s stock worth $1,738,000 after buying an additional 65 shares in the last quarter. Trilogy Capital Inc. raised its holdings in shares of Procter & Gamble by 1.1% in the 4th quarter. Trilogy Capital Inc. now owns 6,289 shares of the company’s stock worth $901,000 after purchasing an additional 67 shares in the last quarter. Cary Street Partners Investment Advisory LLC raised its holdings in shares of Procter & Gamble by 1.8% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company’s stock worth $549,000 after purchasing an additional 67 shares in the last quarter. Emprise Bank raised its holdings in shares of Procter & Gamble by 2.5% in the 3rd quarter. Emprise Bank now owns 2,766 shares of the company’s stock worth $425,000 after purchasing an additional 68 shares in the last quarter. Finally, Lorne Steinberg Wealth Management Inc. raised its holdings in shares of Procter & Gamble by 2.7% in the 4th quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company’s stock worth $376,000 after purchasing an additional 68 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: New product push — P&G launched “Mr. Clean PRO,” a professional cleaning portfolio aimed at commercial customers; this expands addressable markets and can boost revenue durability in cleaning categories. P&G PRO Introduces Mr. Clean PRO
- Positive Sentiment: Brand relevance move — P&G struck a multi‑year, multi‑brand partnership with the WNBA to drive consumer engagement and younger/female audiences, which can support organic growth and marketing ROI. P&G WNBA Partnership Aims To Build Brand Relevance And Investor Interest
- Positive Sentiment: Positive media/strategy coverage — CNBC and other outlets highlighted P&G’s innovation strategy (what management calls its “lifeblood”), which can improve investor sentiment if investors see execution. The strategy P&G calls its ‘lifeblood’ and why it’s key to the stock’s turnaround
- Neutral Sentiment: Management succession in health care — P&G named a new health‑care CEO as a long‑time division leader retires; routine leadership changes can be neutral if transitions are smooth. P&G names new health care CEO as 33-year veteran retires
- Neutral Sentiment: Market commentary — Several outlets noted recent intraday moves (both gains and dips) and index tracking interest (Russell 1000), reflecting higher attention but not new fundamental data. Russell 1000 Index: Tracks Procter Gamble (NYSE:PG) Market Action Closely
- Negative Sentiment: Goldman Sachs trimmed its price target to $155 and kept a neutral rating — reduces upside in analyst consensus and likely weighs on near‑term sentiment. Goldman Sachs Adjusts PT on Procter & Gamble to $155
- Negative Sentiment: Multiple banks lowered targets — RBC cut its PT to $167 (keeps outperform), UBS cut to $166, Piper Sandler lowered to $142 (neutral), and Wells Fargo cut to $158 (still overweight). Collectively these trims reduce analyst upside and create selling pressure. RBC Cuts Price Target on Procter & Gamble to $167 UBS Lowers Procter & Gamble Price Target to $166 Piper Sandler Adjusts PT on Procter & Gamble to $142 Wells Fargo Adjusts PT on Procter & Gamble to $158
- Negative Sentiment: Analyst downgrade impact — Coverage notes the stock moved lower after recent downgrades, illustrating how sentiment shifts among major brokers are driving short‑term volatility. Procter & Gamble Stock Price Down 1.1% After Analyst Downgrade
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
